Staging of bronchial carcinoma.
Survival curves for 173 patients with pathologic Stage I and II bronchial carcinoma were calculated. These curves demonstrated far too much heterogeneity in patients with pathologic Stage I disease. We recommend that the American Joint Committee Staging System be modified so that patients with T1N0 tumors are classified as Stage I disease and patients with T1N1 , T1N0 and T2N1 tumors are classified as Stage II disease.